We believe our therapeutics are highly differentiated, resolve recognizable needs in compelling markets and have therapeutic profiles superior to the standard of care. For more information, please visit www.aratana.com. Contacts For investor inquires: Rhonda Hellums (913) 353-1026 For media inquiries: Rachel Reiff (913) 353-1050 SOURCE Aratana Therapeutics, Inc. Related Links http://www.aratana.com